title: Anosmia as an adverse effect of dorzolamid.
authors.forename: Burak
authors.initials: B
authors.lastname: Turgut
authors.forename: Peykan
authors.initials: P
authors.lastname: Türkçüoğlu
authors.forename: Mete
authors.initials: M
authors.lastname: Güler
authors.forename: Nuray
authors.initials: N
authors.lastname: Akyol
authors.forename: Ulkü
authors.initials: U
authors.lastname: Celiker
authors.forename: Tamer
authors.initials: T
authors.lastname: Demir
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects*; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D000857:Olfaction Disorders / Q000139:chemically induced*; D013449:Sulfonamides / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide